Ted C. Nark - May 5, 2025 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role: Director
Signature: /s/ Denis Butkovic, Attorney-in-Fact
Stock symbol: AMRX
Transactions as of: May 5, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/8/2025, 07:03 PM
Previous filing: May 14, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nark Ted C	Director	C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD, BRIDGEWATER	/s/ Denis Butkovic, Attorney-in-Fact	2025-05-08	0001316851

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMRX	Class A Common Stock	Options Exercise		+40.3K	+13.38%		341K	May 5, 2025	Direct	F1

Showing 1 to 1 of 1 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMRX	Restricted Stock Units	Options Exercise	$0	-40.3K	-100%	$0.00	0	May 5, 2025	Class A Common Stock	40.3K		Direct	F1, F2
transaction	AMRX	Restricted Stock Units	Award	$0	+34.8K		$0.00	34.8K	May 6, 2025	Class A Common Stock	34.8K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2	On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.
F3	Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.